AI Engines For more Details: Perplexity Kagi Labs You
Pancreatitis: Gabexate mesilate has been investigated as a treatment for acute pancreatitis. Studies have suggested that it may help reduce inflammation and tissue damage in the pancreas by inhibiting the activation of pancreatic enzymes and the release of inflammatory mediators. However, its effectiveness in improving clinical outcomes in pancreatitis remains a subject of debate, and further research is needed.
Liver Disease: Gabexate mesilate has been studied for its potential hepatoprotective effects in liver diseases such as hepatitis and liver cirrhosis. It may help reduce liver inflammation and fibrosis by inhibiting the activity of proteases involved in tissue damage. However, more clinical trials are needed to determine its efficacy and safety in the management of liver disorders.
Sepsis: Some studies have suggested that gabexate mesilate may have anti-inflammatory and immunomodulatory effects that could be beneficial in the treatment of sepsis, a life-threatening condition characterized by systemic inflammation and organ dysfunction. It may help mitigate the inflammatory response and prevent organ damage in septic patients, but further research is required to confirm its efficacy in clinical settings.
Surgical Complications: Gabexate mesilate has been investigated for its potential to reduce postoperative complications in patients undergoing surgery, particularly gastrointestinal surgery. By inhibiting proteases involved in tissue injury and inflammation, it may help improve wound healing and reduce the risk of complications such as infection and organ dysfunction. However, its role in surgical practice remains to be established through more rigorous clinical studies.
Other Conditions: Gabexate mesilate has also been explored for its potential therapeutic effects in conditions such as acute respiratory distress syndrome (ARDS), acute lung injury, and acute myocardial infarction. However, the evidence regarding its efficacy in these conditions is limited and inconclusive.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Lactococcus cremoris | Reduces |
species | Lactococcus lactis | Reduces |
species | Streptococcus thermophilus | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 061 | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Streptococcus australis | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Bacteroides sp. CACC 737 | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Streptococcus infantis | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Streptococcus oralis | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Parafannyhessea umbonata | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Butyricimonas virosa | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 431 | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Streptococcus sp. Marseille-Q6470 | species | Decreases |
0 | 1 | Butyricimonas faecalis | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
0 | 1 | Bacteroides humanifaecis | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Streptococcus sanguinis | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | Lactococcus lactis | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Streptococcus mutans | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Campylobacter coli | species | Decreases |
0 | 1 | Streptococcus ilei | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Streptococcus thermophilus | species | Decreases |
0 | 1 | Dysosmobacter welbionis | species | Decreases |
0 | 1 | Rothia dentocariosa | species | Decreases |
0 | 1 | Olsenella uli | species | Decreases |
0 | 1 | Alistipes finegoldii | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.2 | 0.2 | |
Acne | 0.3 | -0.3 | |
ADHD | 3.5 | 0.5 | 6 |
Age-Related Macular Degeneration and Glaucoma | 0.7 | 0.7 | |
Allergic Rhinitis (Hay Fever) | 2.2 | 3.2 | -0.45 |
Allergies | 5.8 | 2.4 | 1.42 |
Allergy to milk products | 1.7 | 0.9 | 0.89 |
Alopecia (Hair Loss) | 1 | 0.1 | 9 |
Alzheimer's disease | 4.8 | 4.8 | 0 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2 | 1 | 1 |
Ankylosing spondylitis | 3.1 | 0.5 | 5.2 |
Anorexia Nervosa | 1.2 | 1.6 | -0.33 |
Antiphospholipid syndrome (APS) | 1.2 | 1.2 | |
Asthma | 4.6 | 2.9 | 0.59 |
Atherosclerosis | 1.7 | 1.6 | 0.06 |
Atrial fibrillation | 1.9 | 0.9 | 1.11 |
Autism | 6.6 | 5.8 | 0.14 |
Autoimmune Disease | 0.9 | 0.8 | 0.13 |
Barrett esophagus cancer | 0.6 | 0.3 | 1 |
benign prostatic hyperplasia | 0.3 | 0.2 | 0.5 |
Biofilm | 2.4 | 2.4 | |
Bipolar Disorder | 0.8 | 0.8 | 0 |
Brain Trauma | 1.2 | 0.8 | 0.5 |
Breast Cancer | 0.8 | 0.8 | |
Cancer (General) | 0.8 | 2.5 | -2.13 |
Carcinoma | 3 | 1.7 | 0.76 |
Celiac Disease | 2.4 | 2.6 | -0.08 |
Cerebral Palsy | 1.7 | 0.7 | 1.43 |
Chronic Fatigue Syndrome | 3.8 | 4.2 | -0.11 |
Chronic Kidney Disease | 3.2 | 2.1 | 0.52 |
Chronic Lyme | 0.3 | 0.4 | -0.33 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.5 | 1.2 | 1.08 |
Chronic Urticaria (Hives) | 1.5 | 0.6 | 1.5 |
Coagulation / Micro clot triggering bacteria | 0.9 | 0.9 | 0 |
Cognitive Function | 1.5 | 1.4 | 0.07 |
Colorectal Cancer | 5.2 | 2 | 1.6 |
Constipation | 0.5 | 0.6 | -0.2 |
Coronary artery disease | 1.7 | 1.8 | -0.06 |
COVID-19 | 8.9 | 9.7 | -0.09 |
Crohn's Disease | 5.4 | 3.4 | 0.59 |
Cushing's Syndrome (hypercortisolism) | 0.2 | -0.2 | |
cystic fibrosis | 0.5 | 1.7 | -2.4 |
d-lactic acidosis (one form of brain fog) | 0.4 | 0.4 | |
deep vein thrombosis | 1.4 | 0.8 | 0.75 |
Denture Wearers Oral Shifts | 2.2 | 2.2 | |
Depression | 7.2 | 7.1 | 0.01 |
Dermatomyositis | 0.3 | 0.3 | 0 |
Eczema | 1.6 | 2.1 | -0.31 |
Endometriosis | 2 | 1.2 | 0.67 |
Eosinophilic Esophagitis | 0.2 | 0.7 | -2.5 |
Epilepsy | 3.2 | 1.6 | 1 |
erectile dysfunction | 0.9 | 0.3 | 2 |
Fibromyalgia | 2 | 1.2 | 0.67 |
Functional constipation / chronic idiopathic constipation | 3.4 | 2.4 | 0.42 |
gallstone disease (gsd) | 2 | 1.1 | 0.82 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.1 | 1.6 | -0.45 |
Generalized anxiety disorder | 2.1 | 2 | 0.05 |
giant cell arteritis | 0.2 | -0.2 | |
Glioblastoma | 0.3 | -0.3 | |
Gout | 1.5 | 0.6 | 1.5 |
Graves' disease | 1.3 | 2.6 | -1 |
Gulf War Syndrome | 0.8 | 1.3 | -0.63 |
Halitosis | 1.5 | 0.4 | 2.75 |
Hashimoto's thyroiditis | 3.1 | 1.5 | 1.07 |
Heart Failure | 2.4 | 1.5 | 0.6 |
hemorrhagic stroke | 0.5 | 0.5 | |
Hidradenitis Suppurativa | 0.7 | 0.4 | 0.75 |
High Histamine/low DAO | 1.3 | 0.3 | 3.33 |
hypercholesterolemia (High Cholesterol) | 0.8 | 0.7 | 0.14 |
hyperglycemia | 2.1 | 1.6 | 0.31 |
Hyperlipidemia (High Blood Fats) | 1 | 0.4 | 1.5 |
hypersomnia | 0.7 | -0.7 | |
hypertension (High Blood Pressure | 3.6 | 4 | -0.11 |
Hypothyroidism | 0.3 | 0.8 | -1.67 |
Hypoxia | 1.8 | 1.8 | |
IgA nephropathy (IgAN) | 1 | 3.2 | -2.2 |
Inflammatory Bowel Disease | 7.4 | 7.4 | 0 |
Insomnia | 2.3 | 2.4 | -0.04 |
Intelligence | 1.4 | 1.4 | |
Intracranial aneurysms | 0.7 | 0.4 | 0.75 |
Irritable Bowel Syndrome | 6.5 | 3.8 | 0.71 |
ischemic stroke | 2.5 | 0.8 | 2.13 |
Liver Cirrhosis | 5.6 | 3.6 | 0.56 |
Long COVID | 4.6 | 5.5 | -0.2 |
Low bone mineral density | 0.6 | -0.6 | |
Lung Cancer | 0.5 | 1.3 | -1.6 |
Lymphoma | 0.3 | 0.3 | |
Mast Cell Issues / mastitis | 1 | 0.3 | 2.33 |
ME/CFS with IBS | 0.6 | 2.4 | -3 |
ME/CFS without IBS | 1.3 | 1.6 | -0.23 |
membranous nephropathy | 0.3 | 0.3 | |
Menopause | 2.4 | 0.7 | 2.43 |
Metabolic Syndrome | 5 | 6.4 | -0.28 |
Mood Disorders | 8.2 | 5.5 | 0.49 |
multiple chemical sensitivity [MCS] | 1.7 | 0.3 | 4.67 |
Multiple Sclerosis | 6.3 | 3.3 | 0.91 |
Multiple system atrophy (MSA) | 1.9 | 0.6 | 2.17 |
myasthenia gravis | 0.6 | 0.5 | 0.2 |
neuropathic pain | 0.1 | 2 | -19 |
Neuropathy (all types) | 1 | 0.9 | 0.11 |
neuropsychiatric disorders (PANDAS, PANS) | 0.9 | 0.9 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4.1 | 4.3 | -0.05 |
NonCeliac Gluten Sensitivity | 1.9 | 0.5 | 2.8 |
Obesity | 8.7 | 6.6 | 0.32 |
obsessive-compulsive disorder | 3.5 | 3.1 | 0.13 |
Osteoarthritis | 2.3 | 1.2 | 0.92 |
Osteoporosis | 1.5 | 1.9 | -0.27 |
pancreatic cancer | 1 | 0.3 | 2.33 |
Parkinson's Disease | 7.2 | 4.7 | 0.53 |
Polycystic ovary syndrome | 2.9 | 2.1 | 0.38 |
Postural orthostatic tachycardia syndrome | 0.2 | 0.3 | -0.5 |
Premenstrual dysphoric disorder | 1 | 1 | |
primary biliary cholangitis | 1 | 1.5 | -0.5 |
Primary sclerosing cholangitis | 2.8 | 1.5 | 0.87 |
Psoriasis | 3.4 | 1.1 | 2.09 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 5.4 | 3 | 0.8 |
Rosacea | 1 | 0.5 | 1 |
Schizophrenia | 6.4 | 2 | 2.2 |
scoliosis | 0.5 | 0 | 0 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 2.2 | 2.1 | 0.05 |
Sleep Apnea | 1.3 | 0.9 | 0.44 |
Slow gastric motility / Gastroparesis | 0.9 | 0.3 | 2 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.8 | 0.6 | 2 |
Stress / posttraumatic stress disorder | 2.3 | 2 | 0.15 |
Systemic Lupus Erythematosus | 2.4 | 1.4 | 0.71 |
Tic Disorder | 0.6 | 1.3 | -1.17 |
Tourette syndrome | 0.9 | 0.2 | 3.5 |
Type 1 Diabetes | 2.9 | 3 | -0.03 |
Type 2 Diabetes | 5.1 | 5.1 | 0 |
Ulcerative colitis | 4.2 | 4.4 | -0.05 |
Unhealthy Ageing | 3.2 | 1.3 | 1.46 |
Vitiligo | 0.8 | 1.1 | -0.38 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]